Ducommun (NYSE:DCO) Downgraded by StockNews.com to “Buy”

Ducommun (NYSE:DCO – Get Free Report) was downgraded by analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a report released on Tuesday. DCO has been the subject of a number of other research reports. Royal Bank of Canada initiated coverage on shares of Ducommun in a research report on Tuesday, December […]

Leave a Reply

Your email address will not be published.

Previous post Biostar Pharmaceuticals (OTCMKTS:BSPM) vs. NRx Pharmaceuticals (NASDAQ:NRXP) Head to Head Contrast
Next post Analysts Set Silicon Motion Technology Co. (NASDAQ:SIMO) Price Target at $80.63